Senores Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for marketing Metoprolol Tartrate and Hydrochlorothiazide Tablet USP, 50 mg/25 mg and ...

Early Tesla backer is developing financing plan to allow fresh shot at FDA approval for ecstasy-based PTSD treatment ...

Morgans analyst Scott Power said investors have dealt with Avita Medical (ASX:AVH) "fairly harshly" after it downgraded its ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

On January 6, the FDA announced the availability of draft guidance on accelerated approval for drugs and biological products, and consideration ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...